Dr. Shelley Boyd runs Canada’s only High Risk dry AMD Clinic. All studies are carried out at the ophthalmology Patient Education & Research Centre (Eye-PERC) established by Dr. Boyd, and in conjunction with St. Michael’s Hospital. The clinic focuses on patient education, risk modification and research.

State of the art imaging equipment allows us to carefully describe your stage of dry AMD and to further identify your particular “flavour” of the disease. This information is vital for correlating subyptes of dry AMD against possible underlying causes and risk of progression.

1) Dry AMD Registry: each patient referred with a diagnosis of high-risk dry AMD is asked if they wish to participate in our research registry. Should you enroll in this registry, Dr Boyd and her team can then compare your information against others, without divulging any personal information. If you agree, you can also be contacted if new studies are initiated.

2) Four-field OCT – A potential screening tool for Reticular Pseudodrusen (RPD): RPD are a special subtype of dry AMD that carry an especially high risk of progression. We specifically evaluate patients for the presence of RPD and use a modified photographic process to look in regions of the retina where RPD are known to occur.

3) The role of inflammation in AMD and related disorders: This study uses a slightly modified imaging method to take specialized images of your eyes that we suggest identify sites of active inflammation. Results from this study will help us understand the role of so-called “innate immunity” in dry AMD, and ultimately, may predict which patients will be best suited for particular types of treatment.

Information for Patients

All patients must be referred by their own eye care specialist

Information for Referring Physicians

Download referral form